Table 6.
Incidence of cutaneous leishmaniasis in IDR− and IDR+ nonvaccinated and vaccinated volunteers.
| Cases of localized cutaneous leishmaniasis and treatment; n = patients, (%) | ||||
|---|---|---|---|---|
| Nonvaccinated controls | Vaccinated volunteers | |||
| IDR− | IDR+ | Post-VTc | Post-VT | |
| 41/69 (59.42) | 5/18 (27.7) | 9/61 (14.75) | 3/10 (30) | |
| S.Ra | 11/41 (26.8) | 4/5 (80) | 4/9 (44.4) | 2/3 (66.7) |
| Glub | 30/41 (73.2) | 1/5 (20) | 5/9 (55.6) | 1/3 (33.3) |
aSR: spontaneous remission. bGlu: meglumine antimoniate or Glucantime. cVT: Leishmania amastigotes (La, Lv, Lb, and Lch) after TLCK treatment and NP-40 extraction.